Free Trial

ConvaTec Group (LON:CTEC) Shares Down 1.7% - Here's What Happened

ConvaTec Group logo with Medical background

Key Points

  • ConvaTec Group's shares dropped 1.7% to GBX 231.80 ($3.12) amid increased trading volume, indicating a possible shift in investor sentiment.
  • Wall Street analysts maintain a consensus of "Buy," with target prices ranging up to GBX 315 from firms like Deutsche Bank and Royal Bank of Canada.
  • Insider trading activity included a purchase of 50,000 shares by Jonny Mason and a sale of 1,250,000 shares by Karim Bitar, reflecting mixed confidence among insiders.
  • Interested in ConvaTec Group? Here are five stocks we like better.

ConvaTec Group PLC (LON:CTEC - Get Free Report)'s stock price traded down 1.7% during mid-day trading on Friday . The company traded as low as GBX 231.80 ($3.12) and last traded at GBX 231.80 ($3.12). 17,813,400 shares changed hands during mid-day trading, an increase of 18% from the average session volume of 15,125,340 shares. The stock had previously closed at GBX 235.80 ($3.18).

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Berenberg Bank lowered their target price on ConvaTec Group from GBX 335 to GBX 330 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of ConvaTec Group in a research report on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 315 price target on shares of ConvaTec Group in a report on Wednesday, July 30th. Royal Bank Of Canada upgraded ConvaTec Group to an "outperform" rating and reduced their price target for the stock from GBX 320 to GBX 315 in a report on Thursday, August 21st. Finally, Peel Hunt reiterated an "add" rating and set a GBX 280 price target on shares of ConvaTec Group in a report on Tuesday, July 29th. Five investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, ConvaTec Group currently has an average rating of "Buy" and an average target price of GBX 309.40.

Read Our Latest Stock Report on ConvaTec Group

ConvaTec Group Price Performance

The company has a 50 day moving average of GBX 236.29 and a 200-day moving average of GBX 256.37. The firm has a market capitalization of £4.72 billion, a P/E ratio of 2,188.68, a P/E/G ratio of 0.93 and a beta of 0.64. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32.

Insider Buying and Selling at ConvaTec Group

In related news, insider Jonny Mason acquired 50,000 shares of the company's stock in a transaction on Thursday, August 28th. The stock was purchased at an average cost of GBX 235 per share, with a total value of £117,500. Also, insider Karim Bitar sold 1,250,000 shares of ConvaTec Group stock in a transaction on Thursday, August 7th. The shares were sold at an average price of GBX 227, for a total value of £2,837,500. 0.91% of the stock is owned by insiders.

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Articles

Should You Invest $1,000 in ConvaTec Group Right Now?

Before you consider ConvaTec Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ConvaTec Group wasn't on the list.

While ConvaTec Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.